Long-term anti-CD4 treatment of MRL/Ipr mice ameliorates immunopathology and lymphoproliferation but fails to suppress rheumatoid factor production

This publication has 31 references indexed in Scilit:

• Prevention and reversal of experimental autoimmune thyroiditis (EAT) in mice by administration of anti-L3T4 monoclonal antibody at different stages of disease development
  Cellular Immunology, 1988
• Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4.
  The Journal of Experimental Medicine, 1985
• Etiopathogenesis of the rheumatoid arthritis–like disease in MRL/1 mice. I. The histomorphologic basis of joint destruction
  Arthritis & Rheumatism, 1985
• Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.
  The Journal of Experimental Medicine, 1985
• Reversal of Experimental Allergic Encephalomyelitis with Monoclonal Antibody to a T-Cell Subset Marker
  Science, 1985
• Characterization of the Murine Antigenic Determinant, Designated L3T4a, Recognized by Monoclonal Antibody GK 1.5: Expression of L3T4a by Functional T Cell Clones Appears to Correlate Primarily with Class II MHC Antigen‐Reactivity
  Immunological Reviews, 1983
• A spontaneous rheumatoid arthritis-like disease in MRL/l mice.
  The Journal of Experimental Medicine, 1982
• Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene.
  The Journal of Experimental Medicine, 1981
• Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2.
  The Journal of Experimental Medicine, 1981
• Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.
  The Journal of Experimental Medicine, 1978